CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Por um escritor misterioso
Descrição
Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
Host genetic factors determining COVID-19 susceptibility and severity - eBioMedicine
Immune response in COVID-19: what is next?
IJMS, Free Full-Text
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies: Molecular Therapy
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
Cellular host factors for SARS-CoV-2 infection
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage - Amor - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies
Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors - ScienceDirect
Frontiers Depletion and Dysfunction of Dendritic Cells: Understanding SARS -CoV-2 Infection
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Biology, Free Full-Text
Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV
de
por adulto (o preço varia de acordo com o tamanho do grupo)
